Sanctuary Advisors LLC Takes Position in Astera Labs, Inc. $ALAB

Sanctuary Advisors LLC acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 11,336 shares of the company’s stock, valued at approximately $5,475,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Connor Clark & Lunn Investment Management Ltd. bought a new position in Astera Labs in the 2nd quarter worth about $77,980,000. Meiji Yasuda Asset Management Co Ltd. bought a new stake in Astera Labs during the 2nd quarter valued at about $254,000. Matters Capital LLC purchased a new position in Astera Labs in the second quarter worth about $241,000. Bank of Nova Scotia bought a new position in shares of Astera Labs in the second quarter worth approximately $50,760,000. Finally, Kirtland Hills Capital Management LLC bought a new position in shares of Astera Labs in the second quarter worth approximately $637,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently commented on ALAB shares. Stifel Nicolaus increased their price objective on Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research report on Wednesday, June 24th. Roth Capital reiterated a “buy” rating and issued a $450.00 price target on shares of Astera Labs in a research note on Wednesday, August 5th. TD Cowen decreased their price objective on shares of Astera Labs from $425.00 to $375.00 and set a “hold” rating for the company in a report on Wednesday, August 5th. Weiss Ratings restated a “hold (c)” rating on shares of Astera Labs in a research report on Tuesday, August 18th. Finally, UBS Group restated a “neutral” rating and issued a $425.00 target price on shares of Astera Labs in a report on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have given a Hold rating to the company’s stock. According to data from MarketBeat, Astera Labs presently has a consensus rating of “Moderate Buy” and an average target price of $333.00.

Astera Labs Trading Down 2.6%

ALAB stock opened at $277.53 on Tuesday. The stock has a market cap of $48.15 billion, a PE ratio of 137.39 and a beta of 3.84. The company has a 50-day moving average price of $350.46 and a 200 day moving average price of $246.41. Astera Labs, Inc. has a 12 month low of $97.89 and a 12 month high of $499.48.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same quarter in the previous year, the business posted $0.44 EPS. The company’s quarterly revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Sell-side analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current year.

Insider Activity

In other Astera Labs news, COO Sanjay Gajendra sold 90,630 shares of Astera Labs stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the transaction, the chief operating officer owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. This trade represents a 7.49% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Jack R. Lazar sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total value of $3,551,700.00. Following the completion of the transaction, the director directly owned 75,688 shares of the company’s stock, valued at $26,882,106.96. The trade was a 11.67% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 419,244 shares of company stock valued at $163,135,169 over the last quarter. Insiders own 10.40% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.